Top Michigan Biotech Startups (34)
Gossamer Bio is a San Diego-based company focused on the discovery and development of novel and differentiated therapeutic products, to address high unmet needs amongst various targeted patient populations. Founded by the former Receptos executive team, Gossamer Bio’s strategy will be to leverage an asset-rich in-licensing environment, with a focus on areas of high unmet need, utilizing a team with...
Hummingbird Bioscience is a data-driven precision biotherapeutics team discovering and developing transformative biologic medicines for hard-to-treat diseases. The Hummingbird Bioscience model combines computational and systems biology, and wet lab drug discovery in a multi-disciplinary, collaborative environment spanning initial discovery through clinical development. We harness this integrated approach across target identification and patient selection, enabling our team to increase the efficiency...
Swift Biosciences develops molecular biology reagents for research and diagnostic applications.
Hygieia is a developer of a diabetes insulin guidance system used to enhance and simplify insulin therapy.
Everist Health is a medicine company developing technologies focused on cancer, cardiovascular diseases and diabetes.
Accuri Cytometers is a medical device company developing cost effective cytometers for laboratories.
ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ: NDRA) is a developer of enhanced ultrasound technologies. ENDRA is developing a next generation Thermo-Acoustic Enhanced UltraSound (TAEUS™) platform to enable clinicians to visualize human tissue composition, function and temperature in ways previously possible only with CT & MRI - at a fraction of the cost, and at the point-of-care. ENDRA's first TAEUS application...
Akadeum Life Sciences, an emerging life science startup, is located in Ann Arbor, MI. Founded in 2014, Akadeum was established to create advanced isolation products and to fundamentally change the way that isolating chemical and biological targets is approached. At Akadeum, we strive to disrupt the status quo by delivering a technology that can isolate any sample, any volume, anywhere.
Essen BioScience is a world leader in the field of cell-based in vitro assays and instrumentation.
Millendo Therapeutics is a biopharmaceutical company previously primarily focused on developing novel treatments for endocrine diseases.
We create high-performing biobased ingredients and materials from sustainable processes at the best value for our customers.
At KBP we are consistently reminded that patient care is the end goal of what we do daily. Our discovery team is highly experienced in identifying new compounds with potential. The close interactions of the discovery and development teams result in a deep pipeline with multiple clinical and pre-clinical compounds. The major organ research group is focused on the maintenance and postponement...
Strata Oncology is a precision oncology company dedicated to transforming cancer care.
Meditrina Pharmaceuticals, a clinical-stage pharmaceutical company, develops innovative therapies that treat women's reproductive disorders.
Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted
LynxDx offers technologies that enable early cancer detection and improvement of patient care.
NeuMoDx Molecular, Inc. operates as a molecular diagnostics company. The company develops solutions for molecular diagnostic (MDx) testing
Phrixus Pharmaceuticals develops and commercializes heart failure-related pharmaceutical products and therapies.
Arbor Assays specializes in the development of high sensitivity assay kits, high-purity inhibitors, and antibodies for drug discovery and basic research. Products for research in non-invasive endocrinology, mitochondrial dysfunction, oxidative stress, cell signaling biomarkers, kidney damage, cholinesterase activity, and other areas are readily available. We also offer custom assay development and testing services. We make unique kits to measure cGAMP,...
We are a preclinical stage AI drug discovery company with a mission to eliminate age-related diseases We use AI to build clinically relevant disease phenotypes in real-world human data and identify diseases with shared biology. Then WES-enabled genetic study on these phenotypes allows us to discover novel targets applicable to several indications at once.
